Latest Insights on RIDE

Biopharmaceutical companies attract millions of investors. All it takes is one blockbuster drug, and the shares are off to the races. Amarin Stock Soared 570% And Is Maintaining Momentum October 19, 2018 by Joseph Hargett Investment Opportunities Biopharmaceutical companies attract millions of investors. All it takes is one blockbuster drug, and the shares are off to the races.
President Trump Is Using “the Bank’s Money” to Fight Wars October 15, 2018 by Chad Shoop Government & Politics Trump's comment sheds light on something I have wrote about before — that we are on the cusp of the next major recession for the global economy.
What Tariffs Really Mean for Your Portfolio October 8, 2018 by Chad Shoop Stocks He brought tariffs up again, asking me how tariffs would have an impact on my investment strategies. My initial reaction somewhat surprised even me.
In the late 1990s and early 2000s, the dot-com bubble was a rat race to be the next major tech company. With that said, today is also a historic moment. Dot-Com Bubble 2.0? October 5, 2018 by Chad Shoop Stocks In the late 1990s and early 2000s, the dot-com bubble was a rat race to be the next major tech company. With that said, today is also a historic moment.
October Market Ride October’s Market Ride October 1, 2018 by Chad Shoop Stocks A much-needed correction is out of the way, I don’t see volatility being an issue in October. Don’t want to sell with the momentum brewing in the market.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"Since I started following your secret over your multiple publications, my $659,000 account is up to $715,000 in just 2 months. I’m up $56,000 in one month alone."

- Will O.

“Loving this. Should have started a long time ago.”

- Jay

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

Share This